Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewNMDA receptor antagonist acting at the glycine site; reported to be more potent than the corresponding kynurenic acid analogue.
分子量 | 274.12 |
储存 | Desiccate at -20°C |
CAS Number | 135025-62-6 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Moroni et al (1991) Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor. Eur.J.Pharmacol. 199 227 PMID: 1720099
关键词: 5,7-Dichlorothiokynurenic acid, 5,7-Dichlorothiokynurenic acid supplier, NMDA, Receptors, 0296, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。
目前没有 5,7-Dichlorothiokynurenic acid 的引用文献。
目前没有该产品的评论。 Be the first to review 5,7-Dichlorothiokynurenic acid and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.